Abbott Laboratories Surges to 48th in Trading Volume with $1.102 Billion Day

Abbott Laboratories reported a trading volume of $1.102 billion on March 27, 2025, marking a 44.02% increase from the previous day. This placed the company at the 48th position in terms of trading volume for the day. The stock has been on an upward trend, rising 3.74% today and 4.58% over the past two days.

Abbott Laboratories has announced that it will be hosting a conference call to discuss its first-quarter 2025 financial results. The call is scheduled for April 24, 2025, at 8:30 AM Eastern Time. Investors and analysts are encouraged to participate in the call to gain insights into the company's performance and future outlook.

Abbott Laboratories has received approval from the U.S. Food and Drug Administration (FDA) for its new diagnostic test, which is designed to detect a specific type of cancer. This approval is expected to boost the company's revenue and market share in the diagnostic testing sector. The new test is anticipated to be launched in the second quarter of 2025.

Abbott Laboratories has also announced that it will be expanding its manufacturing capabilities in the United States. The company plans to invest $100 million in a new production facility, which will create 500 new jobs. This expansion is part of Abbott's strategy to increase its domestic production and reduce its reliance on foreign suppliers.